Alvotech (ALVO)
US$ 8.78997.19%
Price Chart
Key Statistics
Market Cap
$ 2.7B
P/E Ratio
23.59
Revenue (TTM)
$ 587.89M
Volume
106.26K
52W High
$ 13.70
52W Low
$ 7.35
Dividend Yield
0.00%
Beta
0.19
Technicals
50-Day MA
9.6525
200-Day MA
11.1999
52 Week High
13.7
52 Week Low
7.35
About ALVO
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders.
Employees
1012
Headquarters
Luxembourg, Luxembourg
CEO
Mr. Robert Wessman
Latest News
Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma - Insider Monkey
5 days ago • Google News
RCF Opportunities Fund L.P. Ceases to be Substantial Shareholder in Alvo Minerals - TipRanks
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg